Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated sells supplemental health and life insurance through businesses in Japan and the United States. Its news commonly covers earnings from Aflac Japan and Aflac U.S., sales trends in medical, cancer, life, accident, dental, vision, disability and long-term care products, and capital actions such as dividends and share repurchases.
Company updates also address worksite and group benefits, absence and paid-leave administration, reinsurance activity through Aflac Re Bermuda, and health-related initiatives tied to cancer screening and patient support. Product announcements in Japan include Anshin Palette medical insurance, Miraito cancer insurance and Tsumitasu life insurance, while U.S. updates focus on group voluntary benefits, network dental and vision, group life, disability and long-term care riders.
Aflac, in partnership with the Sunrise Association, delivered over 150 'My Special Aflac Ducks' to children facing childhood cancer at Sunrise Day Camp in Long Island. This initiative is part of Aflac's commitment to support children with cancer, which includes over $160 million in contributions to related health centers. Aflac's President emphasized the positive impact of these robots on children’s emotional well-being. Additionally, Aflac is contributing $60,000 to help send 10 children to camp next year, reinforcing its dedication to social responsibility.
Aflac Incorporated has introduced two new consumer-directed insurance products: Aflac Final Expense Whole Life Insurance and Aflac Medicare Supplement Insurance. These offerings, underwritten by Tier One Insurance Company, aim to support individuals and families facing end-of-life expenses and gaps in Medicare coverage. The Final Expense insurance helps cover significant costs such as medical fees, legal expenses, and funerals, with policies available for ages 45 to 80. The Medicare Supplement policies cover expenses not included in Medicare, allowing seniors to enjoy retirement with less financial stress.
Aflac reported Q2 2022 revenues of $5.4 billion, down from $5.6 billion a year ago. Net earnings rose to $1.4 billion ($2.16/share) from $1.1 billion ($1.62/share) due to $564 million in net investment gains. Adjusted earnings decreased 13.1% to $939 million, impacted by a weaker yen and higher expenses. Shareholders' equity fell to $26.4 billion from $33.7 billion in 2021. Aflac Japan saw a 4.2% decline in net earned premiums in yen, while Aflac U.S. reported a 1.0% decline. The company declared a dividend of $0.40 per share, payable on September 1, 2022.
Aflac Incorporated expresses profound sadness over the loss of former Japanese Prime Minister Shinzo Abe, who was instrumental in enhancing Japan's economy and advocating for women's leadership through his 'womenomics' policy. The company honors his legacy and extends condolences to his family and the people of Japan. Aflac, a leading provider of supplemental health insurance, serves over 50 million people and is recognized for its commitment to social responsibility and ethical practices, being named one of the World's Most Admired Companies and included in the Dow Jones Sustainability North America Index.
Aflac Incorporated (NYSE: AFL) announced it will release its second quarter 2022 financial results after market close on August 1, 2022. The release will include earnings materials and a video from CFO Max Brodén, available on the company's Investor Relations website. A conference call is scheduled for 8:00 a.m. (ET) on August 2, 2022, where executives will discuss the results and future outlook. Aflac serves over 50 million people, leading in supplemental health insurance in the U.S. and medical insurance in Japan.
AM Best has upgraded the Long-Term Issuer Credit Rating (ICR) of Aflac Incorporated and its subsidiaries, including Aflac Life Insurance Japan, to 'aa' from 'aa-' while affirming the Financial Strength Rating (FSR) of A+. The outlook for both ratings is now stable. The upgrade reflects Aflac's robust risk management capabilities, strong balance sheet strength, and strong operating performance. Aflac continues to lead in medical insurance in Japan and marketing supplemental insurance in the U.S. The company is focused on growth in various insurance sectors, leveraging technology for direct-to-consumer engagement.
Summary not available.
Summary not available.
Aflac Incorporated has launched a redesigned Group Critical Illness Insurance to better meet the evolving needs of workers in a post-pandemic world. The new product offers enhanced coverage options for acute and chronic conditions, including serious health events, infectious diseases, and mental illnesses. It features customizable benefits like hospitalization for infectious diseases and expanded health screenings. This innovation aims to support employers in maintaining a robust benefits program while addressing rising mental health concerns among employees. Aflac remains a leader in voluntary insurance products.
Summary not available.